Abstract
The effect of electrically induced convulsions was tested on the tolerance to hexobarbital after chronic barbital treatment in male rats. In two experiments barbital was given in the drinking water for more than 20 weeks. The dose was around 200 mg/kg/day. Tolerance was tested with an EEG threshold method where hexobarbital is infused intravenously to obtain a criterion of burst suppression. If on the third abstinent day an electrical convulsion was induced 1 h prior to the threshold determination then the hexobarbital thresholds were reduced compared with barbital-treated animals where no convulsion had been induced (Fig. 2). The distribution of hexobarbital threshold doses tended to be biphasic in the barbital-treated animals where a convulsion had been induced. The animals with the most “normal” thresholds in this distribution did not show any increase in threshold on the 24th abstinent day and had a larger mortality during the observation period after the first barbital treatment. This observation period included a second barbital treatment. Long-term effects of the convulsion thus cannot be excluded in rats if the tolerance on the third abstinent day after a barbital treatment was influenced. No effect of the convulsion was found in untreated controls. The hypothesis that convulsions are means to reduce the changes of physical dependence in the central nervous system was not refuted by the present experiments. A survey of the literature indicates that acetylcholine might be one central nervous transmittor that is involved in these changes.
Similar content being viewed by others
References
Bradley, P. B., Dray, A.: The effects of different anesthetics on responses of brain stem neurones to iontophoretically applied transmitter substances. Brit. J. Pharmacol. 45, 169P-170P (1972)
Collier, H. O. J.: Supersensitivity and dependence. Nature (Lond.) 220, 228–231 (1968)
Crossland, J.: The significance of brain acetylcholine. J. ment. Sci. 99, 247–251 (1953)
Ekwall, T., Wahlström, G.: Tolerance to hexobarbital and supersensitivity to pilocarpine induced by chronic barbital treatment in the rat. Acta pharmacol. (Kbh.) 31, Suppl. I, 2 (1972)
Elliott, K. A. C., Swank, R. L., Henderson, N.: Effects of anesthetics and convulsants on acetylcholine content of brain. Amer. J. Physiol. 162, 469–474 (1950)
Essig, C. F.: Clinical and experimental aspects of barbiturate with-drawal convulsions. Epilepsia 8, 21–30 (1967)
Essig, C. F.: Reduction of barbiturate dependence induced by repeated electroconvulsions. Arch. int. Pharmacodyn. 188, 387–391 (1970)
Giarman, N. J., Pepeu, G.: Drug-induced changes in brain acetylcholine. Brit. J. Pharmacol. 19, 226–234 (1962)
Hemsworth, B. A., Neal, M. J.: The effect of central stimulant drugs on acetylcholine release from rat cerebral cortex. Brit. J. Pharmacol. 34, 543–550 (1968)
Kalant, H., LeBlanc, A. E., Gibbins, R. J.: Tolerance to, and dependence on, some non-opiate psychotropic drugs. Pharmacol. Rev. 23, 135–191 (1971)
Maynert, E. W.: The role of biochemical and neurohumoral factors in the laboratory evaluation of antiepileptic drugs. Epilepsia 10, 145–162 (1969)
Mitchell, J. F.: The spontaneous and evoked release of acetylcholine from the cerebral cortex. J. Physiol. (Lond.) 165, 98–116 (1963)
Nordberg, A., Sundwall, A.: Effect of pentobarbital on endogenous acetylcholine and biotransformation of radioactive choline in different brain regions. In: Cholinergic mechanisms, P. G. Waser, ed., pp. 229–239. New York: Raven Press 1975
Richter, D., Crossland, J.: Variation in acetylcholine content of the brain with physiological state. Amer. J. Physiol. 159, 247–255 (1949)
Schuberth, J., Sparf, B., Sundwall, A.: A technique for the study of acetylcholine turnover in mouse brain in vivo. J. Neurochem. 16, 695–700 (1969)
Wahlström, G.: Estimation of brain sensitivity to hexobarbitone (Enhexymal NFN) in rats by an EEG threshold. Acta pharmacol. (Kbh.) 24, 404–418 (1966a)
Wahlström, G.: Hexobarbitone sleeping time in rats following doses with similar EEG changes. Acta pharmacol. (Kbh.) 24, 419–434 (1966b)
Wahlström, G.: Hexobarbital (Enhexymalum NFN) sleeping times and EEG threshold doses as measurements of tolerance to barbiturates in the rat. Acta pharmacol. (Kbh.) 26, 64–80 (1968)
Wahlström, G.: Changes in a hexobarbital anaesthesia threshold in rats induced by repeated long-term treatment with barbital or ethanol. Psychopharmacologia (Berl.) 19, 366–380 (1971)
Wahlström, G.: The relation between seizure and tolerance in the abstinence syndrom after chronic barbital treatment in the rat. Acta physiol. scand., Suppl. 396, 87 (1973)
Wahlström, G.: Withdrawal in the rat after long-term forced oral barbital administration. Acta pharmacol. (Kbh.) 35, 131–144 (1974)
Wahlström, G.: The acute interaction between cholinergic drugs and a barbiturate. Expt. Brain Res., Suppl. 23, 213 (1975)
Wahström, G.: The interaction between hexobarbital and atropine or methylatropine in male rats. Acta pharmacol. (Kbh.) 38, 72–80 (1976a)
Wahlström, G.: The interaction between pilocarpine and hexobarbital in male rats. Psychopharmacology (accepted for publication 1976b)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wahlström, G. The interaction between electrically induced convulsions and tolerance in the abstinence period after chronic barbital treatments in the rat. Psychopharmacology 48, 239–245 (1976). https://doi.org/10.1007/BF00496855
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00496855